Mitochondria in hematopoiesis and hematological diseases

Oncogene

Volumn 25, Issue 34, 2006, Pages 4757-4767

  Fontenay, M ^a   Cathelin, S ^b   Amiot, M ^c   Gyan, E ^a   Solary, E ^b,c  

^a INSTITUT COCHIN   (France)

^b INSTITUT DE BIOLOGIE   (France)

^c INSERM   (France)

Author keywords

Apoptosis; Leukemia; Mitochondria; Myelodysplastic syndromes; Sideroblastic anemia

Indexed keywords

4' CHLORODIAZEPAM; 5 AMINOLEVULINATE SYNTHASE; 5 AMINOLEVULINATE SYNTHASE 2; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ABC TRANSPORTER; ABC TRANSPORTER B7; ANTIOXIDANT; ARSENIC TRIOXIDE; ASCORBIC ACID; BORTEZOMIB; CASPASE; CLADRIBINE; CYCLOPHILIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOCHROME C; CYTOTOXIC AGENT; DNA POLYMERASE; ERYTHROPOIETIN; ETOPOSIDE; GROWTH FACTOR; IRON; IRON SULFUR PROTEIN; ISOENZYME; LONIDAMINE; MITOCHONDRIAL DNA; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; OBLIMERSEN; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ATAXIA; CARCINOGENESIS; CELL DEATH; CHEMOSENSITIVITY; CYTOSOL; CYTOTOXICITY; DISEASE EXACERBATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROID CELL; ERYTHROPOIESIS; GENE DELETION; GENE MUTATION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEME SYNTHESIS; HOMEOSTASIS; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; IRON METABOLISM; ISCHEMIA; LYMPHOMA; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL GENETICS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; MYELOMA; MYELOMONOCYTIC LEUKEMIA; NEUROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PEARSON SYNDROME; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; SIDEROBLASTIC ANEMIA; THROMBOCYTOPENIA; TUMOR CELL DESTRUCTION; X LINKED SIDEROBLASTIC ANEMIA;

ANIMALS; CELL AGING; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DNA, MITOCHONDRIAL; HEMATOLOGIC DISEASES; HEMATOPOIESIS; HUMANS; IRON; MITOCHONDRIA; MUTATION;

ATAXIA;

EID: 33746905052     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209606     Document Type: Review

References (163)

1. Aerbajinai W, Giattina M, Lee YT, Raffeld M, Miller JL. (2003). Blood 102: 712-717.
2. Astner I, Schulze JO, van den Heuvel J, Jahn D, Schubert WD, Heinz DW. (2005). EMBO J 24: 3166-3177.
3. Azzouz M, Hottinger A, Paterna JC, Zurn AD, Aebischer P, Bueler H. (2000). Hum Mol Genet 9: 803-811.
4. Banker DE, Cooper JJ, Fennell DA, Willman CL, Appelbaum FR, Cotter FE. (2002). Leuk Res 26: 91-106.
5. Becattini B, Sareth S, Zhai D, Crowell KJ, Leone M, Reed JC, Pellecchia M. (2004). Chem Biol 11: 1107-1117.
6. Becker EM, Greer JM, Ponka P, Richardson DR. (2002). Blood 99: 3813-3822.
7. Belzacq AS, Jacotot E, Vieira HL, Mistro D, Granville DJ, Xie Z et al. (2001). Cancer Res 61: 1260-1264.
8. Benesch M, Platzbecker U, Ward J, Deeg HJ, Leisenring W. (2003). Leukemia 17: 2460-2466.
9. Berger G, Hunault-Berger M, Rachieru P, Fontenay-Roupie M, Baranger L, Ifrah N et al. (2001). Hematol J 2: 87-96.
10. Bombrun A, Gerber P, Casi G, Terradillos O, Antonsson B, Halazy S. (2003). J Med Chem 46: 4365-4368.
11. Bouchier-Hayes L, Lartigue L, Newmeyer DD. (2005). J Clin Invest 115: 2640-2647.
12. Bouscary D, Chen YL, Guesnu M, Picard F, Viguier F, Lacombe C et al. (2000). Exp Hematol 28: 784-791.
13. Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J et al. (1997). Leukemia 11: 839-845.
14. Bowen D, Peddie C. (2002). Br J Haematol 118: 345-346; author reply 346.
15. Braun T, Carvalho G, Coquelle A, Vozenin MC, Lepelley P, Hirsch F et al. (2006). Blood 107: 1156-1165.
16. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C et al. (1993). Blood 81: 3091-3096.
17. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F et al. (1996). Science 271: 1423-1427.
18. Carlile GW, Smith DH, Wiedmann M. (2004). Blood 103: 4310-4316.
19. Carlsson G, Aprikyan AA, Tehranchi R, Dale DC, Porwit A, Hellstrom-Lindberg E et al. (2004). Blood 103: 3355-3361.
20. Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E et al. (2003). Blood 101: 1996-2000.
21. Chandra J, Mansson E, Gogvadze V, Kaufmann SH, Albertioni F, Orrenius S. (2002). Blood 99: 655-663.
22. Chauhan D, Li G, Podar K, Hideshima T, Shringarpure R, Catley L et al. (2004). Blood 103: 3158-3166.
23. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A et al. (1997). Science 278: 1966-1968.
24. Chinnery PF, Samuels DC, Elson J, Turnbull DM. (2002). Lancet 360: 1323-1325.
25. Chou WC, Jie C, Kenedy AA, Jones RJ, Trush MA, Dang CV. (2004). Proc Natl Acad Sci USA 101: 4578-4583.
26. Claessens YE, Bouscary D, Dupont JM, Picard F, Melle J, Gisselbrecht S et al. (2002). Blood 99: 1594-1601.
27. Claessens YE, Park S, Dubart-Kupperschmitt A, Mariot V, Garrido C, Chretien S et al. (2005). Blood 105: 4035-4042.
28. Claessens YE, Park S, dubrez-Daloz L, Garrido C, Lacombe C, Drefrus F et al. (2003). Blood 102: 144a. (S1).
29. Cotter PD, May A, Li L, Al-Sabah AI, Fitzsimons EJ, Cazzola M et al. (1999). Blood 93: 1757-1769.
30. Cox TC, Bottomley SS, Wiley JS, Bawden MJ, Matthews CS, May BK. (1994). N Engl J Med 330: 675-679.
31. Craven SE, French D, Ye W, de Sauvage F, Rosenthal A. (2005). Blood 105: 3528-3534.
32. De Botton S, Sabri S, Daugas E, Zermati Y, Guidotti JE, Hermine O et al. (2002). Blood 100: 1310-1317.
33. De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E et al. (1999). Blood 93: 796-803.
34. Decaudin D, Castedo M, Nemati F, Beurdeley-Thomas A, De Pinieux G, Caron A et al. (2002). Cancer Res 62: 1388-1393.
35. del Rio G, Castro-Obregon S, Rao R, Ellerby HM, Bredesen DE. (2001). FEBS Lett 494: 213-219.
36. Derenne S, Monia B, Dean NM, Taylor JK, Rapp MJ, Harousseau JL et al. (2002). Blood 100: 194-199.
37. Ellerby HM, Arap W, Ellerby LM, Kain R, Andrusiak R, Rio GD et al. (1999). Nat Med 5: 1032-1038.
38. Fadeel B, Hassan Z, Hellstrom-Lindberg E, Henter JI, Orrenius S, Zhivotovsky B. (1999). Leukemia 13: 719-728.
39. Fellous R, Coulaud D, el Abed I, Roques BP, Le Pecq JB, Delain E et al. (1988). Cancer Res 48: 6542-6549.
40. Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari Jr AW et al. (2005). Cancer Res 65: 6294-6304.
41. Fleming MD, Campagna DR, Haslett JN, Trenor III CC, Andrews NC. (2001). Genes Dev 15: 652-657.
42. Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, Welsh ML et al. (2004). Blood 104: 2565-2573.
43. Furuyama K, Fujita H, Nagai T, Yomogida K, Munakata H, Kondo M et al. (1997). Blood 90: 822-830.
44. Furuyama K, Sassa S. (2000). J Clin Invest 105: 757-764.
45. Gattermann N. (2000). Leuk Res 24: 141-151.
46. Gattermann N, Retzlaff S, Wang YL, Berneburg M, Heinisch J, Wlaschek M et al. (1996). Br J Haematol 93: 845-855.
47. Gattermann N, Retzlaff S, Wang YL, Hofhaus G, Heinisch J, Aul C et al. (1997). Blood 90: 4961-4972.
48. Gattermann N, Wulfert M, Hofhaus G. (2002). Br J Haematol 119: 1139; author reply 1139-1140.
49. Genini D, Adachi S, Chao Q, Rose DW, Carrera CJ, Cottam HB et al. (2000). Blood 96: 3537-3543.
50. Gersuk GM, Lee JW, Beckham CA, Anderson J, Deeg HJ. (1996). Blood 88: 1122-1123.
51. Gojo I, Zhang B, Fenton RG. (2002). Clin Cancer Res 8: 3527-3538.
52. Gomez-Bougie P, Bataille R, Amiot M. (2004). Eur J Immunol 34: 3156-3164.
53. Gomez-Bougie P, Bataille R, Amiot M. (2005a). Eur J Immunol 35: 971-976.
54. Gomez-Bougie P, Oliver L, Le Gouill S, Bataille R, Amiot M. (2005b). Oncogene 24: 8076-8079.
55. Grasso JA, Myers TJ, Hines JD, Sullivan AL. (1980). Br J Haematol 46: 57-72.
56. Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ. (1999). Blood 94: 87-96.
57. Gupta P, Niehans GA, LeRoy SC, Gupta K, Morrison VA, Schultz C et al. (1999). Leukemia 13: 44-53.
58. Hafid-Medheb K, Augery-Bourget Y, Minatchy MN, Hanania N, Robert-Lezenes J. (2003). Blood 101: 2575-2583.
59. Harigae H, Nakajima O, Suwabe N, Yokoyama H, Furuyama K, Sasaki T et al. (2003). Blood 101: 1188-1193.
60. He L, Luo L, Proctor SJ, Middleton PG, Blakely EL, Taylor RW et al. (2003). Leukemia 17: 2487-2491.
61. Hellstrom-Lindberg E, Schmidt-Mende J, Forsblom AM, Christensson B, Fadeel B, Zhivotovsky B. (2001). Br J Haematol 112: 714-726.
62. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. (1993). Proc Natl Acad Sci USA 90: 8479-8483.
63. Hermine O, Haioun C, Lepage E, d'Agay MF, Briere J, Lavignac C et al. (1996). Blood 87: 265-272.
64. Hishita T, Tada-Oikawa S, Tohyama K, Miura Y, Nishihara T, Tohyama Y et al. (2001). Cancer Res 61: 2878-2884.
65. Houwerzijl EJ, Blom NR, van der Want JJ, Louwes H, Esselink MT, Smit JW et al. (2005). Blood 105: 3472-3479.
66. Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N et al. (2000). J Exp Med 191: 33-46.
67. Jansen B, Schlagbauer-Wadl H, Brown BD, Bryan RN, van Elsas A, Muller M et al. (1998). Nat Med 4: 232-234.
68. Jonasova A, Neuwirtova R, Cermak J, Vozobulova V, Mocikova K, Siskova M et al. (1998). Br J Haematol 100: 304-309.
69. Jourdan M, De Vos J, Mechti N, Klein B. (2000). Cell Death Differ 7: 1244-1252.
70. Jourdan M, Veyrune JL, Vos JD, Redal N, Couderc G, Klein B. (2003). Oncogene 22: 2950-2959.
71. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A et al. (2004). J Immunol 173: 2976-2984.
72. Kaufmann SH, Karp JE, Svingen PA, Krajewski S, Burke PJ, Gore SD et al. (1998). Blood 91: 991-1000.
73. Kerbauy DM, Lesnikov V, Abbasi N, Seal S, Scott B, Deeg HJ. (2005). Blood 106: 3917-3925.
74. Kitagawa M, Yamaguchi S, Takahashi M, Tanizawa T, Hirokawa K, Kamiyama R. (1998). Leukemia 12: 486-492.
75. Kolbus A, Pilat S, Husak Z, Deiner EM, Stengl G, Beug H et al. (2002). J Exp Med 196: 1347-1353.
76. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. (1997). Science 277: 559-562.
77. Kroemer G, de The H. (1999). J Natl Cancer Inst 91: 743-745.
78. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE et al. (2005). Science 309: 481-484.
79. Lacour S, Micheau O, Hammann A, Drouineaud V, Tschopp J, Solary E et al. (2003). Oncogene 22: 1807-1816.
80. Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA et al. (1999). Exp Cell Res 249: 413-421.
81. Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C. (2005). Oncogene 24: 5137-5148.
82. Le Gouill S, Podar K, Amiot M, Hideshima T, Chauhan D, Ishitsuka K et al. (2004). Blood 104: 2886-2892.
83. Letai A. (2005). J Clin Invest 115: 2648-2655.
84. Letai A, Sorcinelli MD, Beard C, Korsmeyer SJ. (2004). Cancer Cell 6: 241-249.
85. Lill R, Kispal G. (2000). Trends Biochem Sci 25: 352-356.
86. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA et al. (2000). Mol Cell 6: 1389-1399.
87. Logette E, Le Jossic-Corcos C, Masson D, Solier S, Sequeira-Legrand A, Dugail I et al. (2005). Mol Cell Biol 25: 9621-9631.
88. Marchetti P, Zamzami N, Joseph B, Schraen-Maschke S, Mereau-Richard C, Costantini P et al. (1999). Cancer Res 59: 6257-6266.
89. Marczin N, El-Habashi N, Hoare GS, Bundy RE, Yacoub M. (2003). Arch Biochem Biophys 420: 222-236.
90. Matthes TW, Kindler V, Leuba F, French LE, Chapuis B, Beris P et al. (2002). Leukemia 16: 1319-1323.
91. Matthes TW, Meyer G, Samii K, Beris P. (2000). Br J Haematol 111: 843-852.
92. Meijerink JP, Mensink EJ, Wang K, Sedlak TW, Sloetjes AW, de Witte T et al. (1998). Blood 91: 2991-2997.
93. Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT. (1999). J Biol Chem 274: 7987-7992.
94. Michels J, Johnson PW, Packham G. (2005). Int J Biochem Cell Biol 37: 267-271.
95. Moreaux J, Legouffe E, Jourdan E, Quittet P, Reme T, Lugagne C et al. (2004). Blood 103: 3148-3157.
96. Moshynska O, Sankaran K, Pahwa P, Saxena A. (2004). J Natl Cancer Inst 96: 673-682.
97. Motoyama N, Kimura T, Takahashi T, Watanabe T, Nakano T. (1999). J Exp Med 189: 1691-1698.
98. Mufti GJ. (2004). Best Pract Res Clin Haematol 17: 543-557.
99. Nakajima O, Takahashi S, Harigae H, Furuyama K, Hayashi N, Sassa S et al. (1999). EMBO J 18: 6282-6289.
100. Napier I, Ponka P, Richardson DR. (2005). Blood 105: 1867-1874.
101. Nencioni A, Hua F, Dillon CP, Yokoo R, Scheiermann C, Cardone MH et al. (2005). Blood 105: 3255-3262.
102. Nie G, Sheftel AD, Kim SF, Ponka P. (2005). Blood 105: 2161-2167.
103. Ogasawara Y, Nakayama K, Tarnowka M, McCoy Jr JP, Kajigaya S, Levin BC et al. (2005). Blood 106: 3271-3284.
104. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA et al. (2005). Nature 435: 677-681.
105. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. (2003). Nature 426: 671-676.
106. Oren Z, Ramesh J, Avrahami D, Suryaprakash N, Shai Y, Jelinek R. (2002). Eur J Biochem 269: 3869-3880.
107. Oudard S, Carpentier A, Banu E, Fauchon F, Celerier D, Poupon MF et al. (2003). J Neurooncol 63: 81-86.
108. Pandolfo M. (2003). Semin Pediatr Neurol 10: 163-172.
109. Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A. (2000). Blood 96: 3932-3938.
110. Pasanen AV, Vuopio P, Borgstrom GH, Tenhunen R. (1981). Scand J Haematol 27: 35-44.
111. Pearson HA, Lobel JS, Kocoshis SA, Naiman JL, Windmiller J, Lammi AT et al. (1979). J Pediatr 95: 976-984.
112. Ponka P. (1999). Am J Med Sci 318: 241-256.
113. Puthier D, Bataille R, Amiot M. (1999). Eur J Immunol 29: 3945-3950.
114. Raje N, Kumar S, Hideshima T, Roccaro A, Ishitsuka K, Yasui H et al. (2005). Blood 106: 1042-1047.
115. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R et al. (1995). Blood 86: 268-276.
116. Reddy PL, Shetty VT, Dutt D, York A, Dar S, Mundle SD et al. (2002). Br J Haematol 116: 564-575.
117. Richardson DR, Ponka P, Vyoral D. (1996). Blood 87: 3477-3488.
118. Rotig A, Cormier V, Koll F, Mize CE, Saudubray JM, Veerman A et al. (1991). Genomics 10: 502-504.
119. Rudin CM, Kozloff M, Hoffman PC, Edelman MJ, Karnauskas R, Tomek R et al. (2004). J Clin Oncol 22: 1110-1117.
120. Sandrelli A, De Fabritiis P, Capua A, Mandelli F, Zupi G, Leonetti C. (1992). Eur J Cancer 28A: 1633-1636.
121. Sawada M, Hayes P, Matsuyama S. (2003). Nat Cell Biol 5: 352-357.
122. Schiller AB, Clark WS, Cotsonis G, Lawson D, DeRose PB, Cohen C. (2002). Cytometry 50: 203-209.
123. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM et al. (2002). Cell 109: 335-346.
124. Schmitt CA, Rosenthal CT, Lowe SW. (2000). Nat Med 6: 1029-1035.
125. Serkova NJ, Christians U, Benet LZ. (2004). Mol Interv 4: 97-107.
126. Shetty V, Hussaini S, Alvi S, Joshi L, Shaher A, Dangerfield B et al. (2002). Br J Haematol 116: 817-825.
127. Shimada Y, Okuno S, Kawai A, Shinomiya H, Saito A, Suzuki M et al. (1998). J Hum Genet 43: 115-122.
128. Shin MG, Kajigaya S, Levin BC, Young NS. (2003). Blood 101: 3118-3125.
129. Shin MG, Kajigaya S, McCoy Jr JP, Levin BC, Young NS. (2004). Blood 103: 553-561.
130. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC et al. (2002). Nat Med 8: 68-74.
131. Shirihai OS, Gregory T, Yu C, Orkin SH, Weiss MJ. (2000). EMBO J 19: 2492-2502.
132. Singh KK, Russell J, Sigala B, Zhang Y, Williams J, Keshav KF. (1999). Oncogene 18: 6641-6646.
133. Sordet O, Rebe C, Leroy I, Bruey JM, Garrido C, Miguet C et al. (2001). Blood 97: 3931-3940.
134. Sordet O, Rebe C, Plenchette S, Zermati Y, Hermine O, Vainchenker W et al. (2002). Blood 100: 4446-4453.
135. Takada S, Shirakata Y, Kaneniwa N, Koike K. (1999). Oncogene 18: 6965-6973.
136. Taketani S, Kakimoto K, Ueta H, Masaki R, Furukawa T. (2003). Blood 101: 3274-3280.
137. Tehranchi R, Fadeel B, Forsblom AM, Christensson B, Samuelsson J, Zhivotovsky B et al. (2003). Blood 101: 1080-1086.
138. Tehranchi R, Fadeel B, Schmidt-Mende J, Forsblom AM, Emanuelsson E, Jadersten M et al. (2005). Clin Cancer Res 11: 6291-6299.
139. Testa U. (2004). Leukemia 18: 1176-1199.
140. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE et al. (2004). Nature 429: 417-423.
141. Tura S, Cavo M, Gobbi M, Franchi P. (1984). Oncology 41: Suppl 1, 90-93.
142. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL et al. (1998). Immunity 9: 267-276.
143. Waldmeier PC, Feldtrauer JJ, Qian T, Lemasters JJ. (2002). Mol Pharmacol 62: 22-29.
144. Walker A, Taylor ST, Hickman JA, Dive C. (1997). Cancer Res 57: 1939-1945.
145. Walsh M, Lutz RJ, Cotter TG, O'Connor R. (2002). Blood 99: 3439-3448.
146. Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG. (2001). Proc Natl Acad Sci USA 98: 4038-4043.
147. Wang JL, Zhang ZJ, Choksi S, Shan S, Lu Z, Croce CM et al. (2000). Cancer Res 60: 1498-1502.
148. Watabe M, Machida K, Osada H. (2000). Cancer Res 60: 5214-5222.
149. Waters JS, Webb A, Cunningham D, Clarke PA, Raynaud F, di Stefano F et al. (2000). J Clin Oncol 18: 1812-1823.
150. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. (2001). Science 292: 727-730.
151. Weisberg EL, Koya K, Modica-Napolitano J, Li Y, Chen LB. (1996). Cancer Res 56: 551-555.
152. Weisleder N, Taffet GE, Capetanaki Y. (2004). Proc Natl Acad Sci USA 101: 769-774.
153. Woo M, Hakem R, Furlonger C, Hakem A, Duncan GS, Sasaki T et al. (2003). Nat Immunol 4: 1016-1022.
154. Yakes FM, Van Houten B. (1997). Proc Natl Acad Sci USA 94: 514-519.
155. Yamamoto K, Abe S, Nakagawa Y, Suzuki K, Hasegawa M, Inoue M et al. (2004). Leuk Res 28: 1203-1211.
156. Yamamoto M, Nakajima O. (2000). Int J Hematol 72: 157-164.
157. Zamzami N, Kroemer G. (2001). Nat Rev Mol Cell Biol 2: 67-71.
158. Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, Valensi F et al. (2001). J Exp Med 193: 247-254.
159. Zhang B, Potyagaylo V, Fenton RG. (2003). Oncogene 22: 1848-1859.
160. Zhivotovsky B, Orrenius S. (2005). Biochem Biophys Res Commun 331: 859-867.
161. Zhong Q, Gao W, Du F, Wang X. (2005). Cell 121: 1085-1095.
162. Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P. (2003). Blood 101: 4098-4104.
163. Zinkel SS, Ong CC, Ferguson DO, Iwasaki H, Akashi K, Bronson RT et al. (2003). Genes Dev 17: 229-239.